chr5-79024136-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_013391.3(DMGDH):c.2250+135T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00257 in 777,760 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0081 ( 21 hom., cov: 33)
Exomes 𝑓: 0.0012 ( 10 hom. )
Consequence
DMGDH
NM_013391.3 intron
NM_013391.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.443
Genes affected
DMGDH (HGNC:24475): (dimethylglycine dehydrogenase) This gene encodes an enzyme involved in the catabolism of choline, catalyzing the oxidative demethylation of dimethylglycine to form sarcosine. The enzyme is found as a monomer in the mitochondrial matrix, and uses flavin adenine dinucleotide and folate as cofactors. Mutation in this gene causes dimethylglycine dehydrogenase deficiency, characterized by a fishlike body odor, chronic muscle fatigue, and elevated levels of the muscle form of creatine kinase in serum. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 5-79024136-A-G is Benign according to our data. Variant chr5-79024136-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 1318070.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0081 (1234/152344) while in subpopulation AFR AF= 0.0272 (1129/41564). AF 95% confidence interval is 0.0258. There are 21 homozygotes in gnomad4. There are 601 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 21 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DMGDH | NM_013391.3 | c.2250+135T>C | intron_variant | ENST00000255189.8 | NP_037523.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMGDH | ENST00000255189.8 | c.2250+135T>C | intron_variant | 1 | NM_013391.3 | ENSP00000255189 | P1 | |||
DMGDH | ENST00000523732.1 | c.1767+135T>C | intron_variant | 1 | ENSP00000430972 | |||||
DMGDH | ENST00000517853.5 | c.*1012+135T>C | intron_variant, NMD_transcript_variant | 2 | ENSP00000428995 | |||||
DMGDH | ENST00000518477.5 | c.*1484+135T>C | intron_variant, NMD_transcript_variant | 2 | ENSP00000427834 |
Frequencies
GnomAD3 genomes AF: 0.00807 AC: 1229AN: 152226Hom.: 21 Cov.: 33
GnomAD3 genomes
AF:
AC:
1229
AN:
152226
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00122 AC: 766AN: 625416Hom.: 10 AF XY: 0.00101 AC XY: 338AN XY: 333080
GnomAD4 exome
AF:
AC:
766
AN:
625416
Hom.:
AF XY:
AC XY:
338
AN XY:
333080
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00810 AC: 1234AN: 152344Hom.: 21 Cov.: 33 AF XY: 0.00807 AC XY: 601AN XY: 74502
GnomAD4 genome
AF:
AC:
1234
AN:
152344
Hom.:
Cov.:
33
AF XY:
AC XY:
601
AN XY:
74502
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 17, 2021 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at